Integrated Clinicopathology and Biorespository Core

综合临床病理学和生物仓库核心

• 批准号: 9122382
• 负责人: Matthew D Ringel
• 金额: $ 27.29万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9122382
• 关键词: Back; Basic Science; Biological; Blood specimen; Cancer Center; Clinical; Clinical Data; DNA; Data; Ensure; Formalin; Freezing; Goals; Human; Institution; Instruction; Knowledge; Malignant - descriptor; Malignant neoplasm of thyroid; Ohio; Outcome; Paraffin Embedding; Process; Quality Control; Research; Research Activity; Resources; Sampling; Specimen; Techniques; Thyroid Gland; Tissue Sample; Tissues; Translating; Translational Research; Universities; Validation; bench to bedside; biobank; clinical care; novel; peripheral blood; prospective; sample collection; sound

The goal of this Core is to provide high quality clinical data and subject samples for use in the scientific projects of the SPORE. To provide these resources. Core A will utilize and expand upon clinical and biospecimen resources that already exist at each institution. For projects in which additional or different samples/data are required, prospective collection of these samples and their corresponding clinical information will be supported through Core A. RELEVANCE (See instructions): Core A is essential to ensure that all research activities in this SPORE utilizing human samples are provided with sound clinical and pathological information, that the data are efficiently and accurately managed, and that distribution of samples and data occurs in a reliable and timely manner.

该核心的目标是提供高质量的临床数据和受试者样本以供科学研究使用 孢子的项目。提供这些资源。核心A将利用和扩展临床和 每个机构已有的生物标本资源。对于项目中，额外的或不同的 需要样本/数据，前瞻性收集这些样本及其相应的临床 信息将通过核心A得到支持。 相关性（参见说明）： 核心A对于确保提供本SPORE中使用人体样本的所有研究活动至关重要 有健全的临床和病理信息，数据得到有效和准确的管理， 以可靠和及时的方式分发样本和数据。